219 related articles for article (PubMed ID: 1904181)
21. [Diclonal gammopathy (IgG kappa, IgA lambda) with nephrotic syndrome terminating into IgA lambda myeloma after three years--report of a case].
Shigemi H; Murakami S; Oku N; Itoh K; Fujita N; Nakanishi S; Shimazaki C; Inoue D; Takahashi H; Nakagawa M
Rinsho Ketsueki; 1990 Feb; 31(2):209-13. PubMed ID: 2109804
[TBL] [Abstract][Full Text] [Related]
22. Synthesis of abnormal heavy and light chains in multiple myeloma with visceral deposition of monoclonal immunoglobulin.
Preud'Homme JL; Morel-Maroger L; Brouet JC; Mihaesco E; Mery JP; Seligmann M
Clin Exp Immunol; 1980 Dec; 42(3):545-53. PubMed ID: 6783355
[TBL] [Abstract][Full Text] [Related]
23. Distribution of heavy chain classes and light chain types in 757 cases of monoclonal gammapathies.
Fine JM; Lambin P
Biomedicine; 1975 Oct; 23(8):323-7. PubMed ID: 821548
[TBL] [Abstract][Full Text] [Related]
24. Multiple myeloma presenting as dense deposit disease. Light chain nephropathy.
Knobler H; Kopolovic J; Kleinman Y; Rubinger D; Silver J; Friedlaender MM; Popovtzer MM
Nephron; 1983; 34(1):58-63. PubMed ID: 6406920
[TBL] [Abstract][Full Text] [Related]
25. Coincident multiple myeloma and non-Hodgkin's lymphoma with 2 serum monoclonal immunoglobulins.
Grau E; Soler J; Puig J; Brunet S; Pujol-Moix N; Rodriguez JL; Domingo-Albós A
Acta Haematol; 1986; 75(3):183-5. PubMed ID: 3092538
[TBL] [Abstract][Full Text] [Related]
26. [Contribution of bone biopsy with histomorphometry in the evaluation of monoclonal gammopathy].
Alexandre C; Bataille R; Chappard D; Dessauw P; Sany J; Riffat G
Rev Rhum Mal Osteoartic; 1987 Nov; 54(11):717-21. PubMed ID: 3423714
[TBL] [Abstract][Full Text] [Related]
27. [Case of light-chain plasmacytic leukemia].
Dinkov L; Ivanov B; Glavincheva I
Vutr Boles; 1981; 20(6):128-32. PubMed ID: 6801860
[TBL] [Abstract][Full Text] [Related]
28. [Light chain or monoclonal immunoglobulin deposit disease. Apropos of a case associated with light chain myeloma].
Clerc D; Delfraissy JF; Delrieu F; Amoudry C; Bisson M; Massias P
Rev Rhum Mal Osteoartic; 1985 Jan; 52(1):51-6. PubMed ID: 3922045
[No Abstract] [Full Text] [Related]
29. Asymptomatic (benign) monoclonal gammopathy--a study of 100 patients.
Pick AI; Shoenfeld Y; Skvaril F; Schreibman S; Fröhlichman R; Weiss H; Pinkhas J
Ann Clin Lab Sci; 1977; 7(4):335-43. PubMed ID: 409332
[No Abstract] [Full Text] [Related]
30. IgA-kappa type multiple myeloma affecting proximal and distal renal tubules.
Minemura K; Ichikawa K; Itoh N; Suzuki N; Hara M; Shigematsu S; Kobayashi H; Hiramatsu K; Hashizume K
Intern Med; 2001 Sep; 40(9):931-5. PubMed ID: 11579959
[TBL] [Abstract][Full Text] [Related]
31. Glomerular lesions in monoclonal gammopathies and mixed essential cryoglobulinemias IgG-IgM.
Verroust P; Mery JP; Morel-Maroger L; Clauvel JP; Richet G; Bouteiller AM; Fumagalli N
Adv Nephrol Necker Hosp; 1971; 1():161-94. PubMed ID: 4377644
[TBL] [Abstract][Full Text] [Related]
32. Myeloma proteins in adult Chinese patients.
Lin KT
Zhonghua Min Guo Wei Sheng Wu Xue Za Zhi; 1977 Jun; 10(1-2):28-36. PubMed ID: 408113
[No Abstract] [Full Text] [Related]
33. Light-heavy chain deposition disease progressing to multiple myeloma.
Daliani D; Weber D; Alexanian R
Am J Hematol; 1995 Dec; 50(4):296-8. PubMed ID: 7485106
[TBL] [Abstract][Full Text] [Related]
34. The physiopathological significance of benign monoclonal gammopathy: a study of 64 cases.
Carter A; Tatarsky I
Br J Haematol; 1980 Dec; 46(4):565-74. PubMed ID: 7437335
[TBL] [Abstract][Full Text] [Related]
35. Medical and technical usefulness of measurement of kappa and lambda immunoglobulin light chains in serum with an M-component.
Lievens MM
J Clin Chem Clin Biochem; 1989 Aug; 27(8):519-23. PubMed ID: 2509630
[TBL] [Abstract][Full Text] [Related]
36. [Tumor-forming type IgA (kappa) multiple myeloma developed into polyclonal hyper gamma-globulinemia after M-protein loss].
Wakita M; Kotani S; Sezaki T; Murakami M; Ishii H; Hoshijima T; Nakayama S
Rinsho Ketsueki; 1991 Sep; 32(9):964-9. PubMed ID: 1942542
[TBL] [Abstract][Full Text] [Related]
37. Light chain nephropathy: histological and clinical aspects in 15 cases.
Confalonieri R; Barbiano di Belgiojoso G; Banfi G; Ferrario F; Bertani T; Pozzi C; Casanova S; Lupo A; De Ferrari G; Minetti L
Nephrol Dial Transplant; 1988; 3(2):150-6. PubMed ID: 3140081
[TBL] [Abstract][Full Text] [Related]
38. Distribution of immunoglobulin-containing cells in bone marrow and lymphoid tissues in patients with monoclonal gammapathy.
Turesson I
Acta Med Scand; 1978; 203(4):247-55. PubMed ID: 347889
[TBL] [Abstract][Full Text] [Related]
39. The predictive power of serum kappa/lambda ratios for discrimination between monoclonal gammopathy of undetermined significance and multiple myeloma.
Bergón E; Miravalles E; Bergón E; Miranda I; Bergón M
Clin Chem Lab Med; 2005; 43(1):32-7. PubMed ID: 15653439
[TBL] [Abstract][Full Text] [Related]
40. Clinicopathological significance of monoclonal IgA deposition in patients with IgA nephropathy.
Nagae H; Tsuchimoto A; Tsuruya K; Kawahara S; Shimomura Y; Noguchi H; Masutani K; Katafuchi R; Kitazono T
Clin Exp Nephrol; 2017 Apr; 21(2):266-274. PubMed ID: 27170372
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
